Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 55 results found. Search for [ UK vaccine candidates ]

Results 1 to 21 of 55
BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


Rajeev Dubey & Manoj Sharma
September 9, 2020
\"AstraZeneca has paused the trials due to some unrelated issue with a patient in the UK, and we'll have to wait for AstraZeneca to explain what happened but this is not vaccine-related,\" says Poonawalla


PTI
September 9, 2020
The CP therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus patient to help kickstart the immune system to fight the infection


BusinessToday.In
September 9, 2020
AstraZeneca said that an adverse reaction was observed in one of the volunteers in the UK. According to the pharmaceutical firm, the nature of the adverse reaction remained unknown, though the participant is expected to recover


Reuters
September 3, 2020
COVAX is co-led by GAVI, the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), and is designed to discourage national governments from hoarding COVID-19 vaccines and to focus on first vaccinating the most high-risk people in every country


Reuters
August 29, 2020
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


BusinessToday.In
August 29, 2020
Coronavirus vaccine update: 'We are delivering life-saving therapies and (we) will produce a vaccine before the end of this year or maybe even sooner. We will defeat the virus and the pandemic,' US President Donald Trump said


Reuters
August 24, 2020
There are no approved vaccines for COVID-19, but AstraZeneca's shot, called AZD1222, is widely seen as one of the leading candidates


BusinessToday.In
August 18, 2020
Oxford vaccine news update: The government had formed a coronavirus vaccine expert committee that held discussions on the distribution plans of the vaccine. The trials would be conducted across 10 centres at first


BusinessToday.In
August 18, 2020
SII confirms it's in talks with multiple investors for its COVID-19 vaccine production plans; it recently received $150 million from Bill & Melinda Gates Foundation to ramp-up production


Reuters
August 17, 2020
Over 100,000 people have volunteered to take part in vaccine trials, Britain's business ministry said, but more volunteers are needed to make sure candidate shots work for everyone


BusinessToday.In
August 8, 2020
Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil


BusinessToday.In
August 4, 2020
Coronavirus vaccine news update: Russia has said that it would start production of one of its COVID-19 vaccine candidates by Gamaleya Institute of Epidemiology and Microbiology in September


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


PAGES 1 OF 3  123